| 11.38 Delayed Data As of Oct 11 |  0.00 / 0.00%Today’s Change | 9.87 Today|||52-Week Range 32.32 | -10.39% Year-to-Date |
| Previous close | 11.38 |
| Today’s open | 11.31 |
| Day’s range | 11.24 - 11.57 |
| Volume | 350,887 |
| Average volume (3 months) | 477,321 |
| Market cap | $556.4M |
| Earnings growth (last year) | -675.81% |
| Earnings growth (this year) | +17.49% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -61.89% |
| P/E ratio | NM |
| Price/Sales | 8.65 |
| Price/Book | 1.98 |
| Today’s change | Today’s % change | |
|---|---|---|
| HSKAHeska Corp | 0.00 | 0.00% |
| GNFTGenfit SA | 0.00 | 0.00% |
| RVNCRevance Therapeutics... | +0.31 | +2.55% |
| AKROAkero Therapeutics I... | 0.00 | 0.00% |
| Next reporting date | November 14, 2019 |
| EPS forecast (this quarter) | -$0.92 |
| Annual revenue (last year) | $60.1M |
| Annual profit (last year) | -$171.5M |
| Net profit margin | -285.18% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Scott E. Koenig |
Chief Financial Officer, Secretary & Senior VP James Karrels |
Corporate headquarters Rockville, Maryland |
